Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)*

Thumbnail Image
Identifiers
URI: http://hdl.handle.net/11268/4216
DOI: 10.1097/CCM.0000000000000554

Publication date

2015

Authors

Vincent, Jean-Louis
Privalle, Christopher
Singer, Mervyn
Boehm, Erwin

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

The objective of this study is to compare the effectiveness and safety of the hemoglobin-based nitric oxide scavenger, pyridoxalated hemoglobin polyoxyethylene, against placebo in patients with vasopressor-dependent distributive shock.

Description

UNESCO Subjects

Enfermedad cardiovascular

Keywords

Bibliographic reference

Vincent, J. L., Privalle, C. T., Singer, M., Lorente, J. A., Boehm, E., Meier-Hellmann, A., ... & DeAngelo, J. (2015). Multicenter, randomized, placebo-controlled phase III study of pyridoxalated hemoglobin polyoxyethylene in distributive shock (PHOENIX)*. Critical Care Medicine, 43(1), 57-64.

Type of document

journal article

Collections

Otras Áreas de Investigación de Salud